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Abstract 
          
         We have used reduced doses of Chinese herbs for estimation of urinary tract infections (UTIs) patients with stable 
impairment of renal function. A total of 33 adult female patients with moderately impaired renal function and symptomatic 
UTIs were included in this study. Urine cultures were carried out. Patients were monitored clinically and with various 
laboratory tests. Chinese herbal concoction divided by milligrams of creatinine per 100 ml were orally administrated for ten 
days. Three patients were excluded from final analysis. Most of the patients responded symptomatically to treatment. Chinese 
herbs eradicated the primary pathogen in 68.7% of the patients at the day 10 of treatment. Two patients relapsed (one had 
abbreviated courses of therapy) 6 to 8 days posttreatment. Organisms which recurred included Escherichia coli and 
Pseudomonas aeruginosa. Bacterial reinfections occurred 5 to 8 days posttreatment in four patients. Adverse reactions 
observed among the 30 patients were rare. Nausea (6.67%) and mild elevation of hepatic enzymes (3.33%) were probably 
drug related. Nausea disappeared when the therapy ended. Elevated hepatic enzymes resumed at the 2-week follow-up. Two 
patients demonstrated slight increases in serum creatinine on day 10 of treatment. One patient had a 12.5% elevation over 
baseline and the other had a 13.0% elevation. Serum creatinine values had improved in these two patients at 4-week 
follow-up.  Chinese herbal medicine was effective and safe in the treatment of UTIs with renal insufficiency.  
. 
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Introduction 
 
         Complicated urinary tract infections (UTIs) may occur in all age groups and are frequently associated with either 
structural or functional urinary tract abnormalities. Examples include foreign bodies such as calculi (stones), indwelling 
catheters or other drainage devices, obstruction, immunosuppression, and renal failure (Lichtenberger et al., 2008). The 
management of UTIs in patients with chronic renal insufficiency has attracted little attention. An in-depth literature review 
identified only one publication that addressed the subject (Bennett and Craven, 1976). Many UTIs-controlled studies 
excluded patients with impaired renal function. UTIs in these patients seems not to be a problem that is sufficient to generate 
academic interest. 
         Herbal remedies are herbs, herbal materials, herbal preparations and finished herbal products, that contain as 
active ingredients parts of plants, or plant materials, or combinations thereof used to treat a multitude of ailments throughout 
the world (WHO, 2002). In our previous study, some Chinese herbs were shown to be clinically effective and relatively free 
from toxic side effects when given orally to patients of UTIs caused by fluoroquinolone-resistant strains. The patients 
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participating in the study had normal renal function (Tong et al., 2011b). 
         However, every drug is a potential poison. Thus some herbal remedies are toxic especially when used over a 
period. The maintenance dose for Chinese herbal drugs in continuous drug administration is inversely proportional to the 
half-life of the drug at reduced renal function. It is postulated that dividing the normal daily dosage by the patient's serum 
creatinine (in milligrams per 100 ml) will result in effective serum and urine concentrations in the treatment of UTIs and not 
cause an accumulation of drug in the patient's serum. In the present study, we have used reduced doses of these Chinese herbs 
for estimation of serious UTIs patients with stable impairment of renal function, based solely on pretreatment serum 
creatinine. 
 
 
Materials and methods 
 
         Study protocol was approved by the First Affilliated Hospital to Changchun University of Chinese Medicine. 
Protocol summaries were reviewed by the participants, and written, informed consent was obtained on the day of the study 
after a detailed explanation of the study purpose and methods. A total of 33 adult female patients with moderately impaired 
renal function (serum creatinine, 1.5 to 2.5 mg/100 ml) and symptomatic UTIs (2 with bacteremia) were included in this 
study from April 2008 to September 2009. The patients were generally older (36 to 75 years old; mean, 58 years) with 
significant underlying diseases. Among group, 21 had neurogenic bladders, vesicoureteral reflux, calculi, or obstructive 
lesions, 11 were diabetes, and 8 required intermittent or indwelling urinary catheters; and 25 required hospitalization for their 
infections or were hospitalized for other physical illnesses when treatment was initiated. 
         The diagnosis of UTIs was based on the presence of signs and symptoms suggestive of UTIs, the presence of 
pyuria and bacteriuria. Urine cultures with colony counts ≥105 CFU were carried out on midstream clean-catch specimens 
before treatment. The urine cultures were repeated at 5 days, 10 days, and 1 week after the treatment. All urine samples were 
plated initially on blood agar plates and were quantitated by pour plates or calibrated wire loops. Cultures were observed for 
growth for 48 hrs. All bacterial isolates were identified by standard procedures (Edwards and Ewing,1955). 
         Patients were monitored clinically and with various laboratory tests to determine the incidences of adverse 
reactions. Blood urea nitrogen, serum creatinine, creatinine clearance, hemoglobin, hematocrit, total leukocyte count with 
differential count, alkaline phosphatase, lactate dehydrogenase, serum glutamic oxaloacetic transaminase, and serum bilirubin 
were determined in all patients before and after the study. The criterion for nephrotoxicity was a 20% elevation in creatinine 
over baseline. 
         All the patients were orally administrated Chinese herbal concoction. The prescription was as follow: Tong Cao 
(Stachyurus himalaicus Hook.f.et Thoms) 20g, Hua Shi (Talcum) 15g, Chi Shao (Paeonia lactiflora Pall.) 15g, Hui Xiang 
(Foeniculum vulgare Mill.) 15g, Guan Gui (Cinnamomum cassia Presl) 15g, Li Zhihe (Litchi chinensis Sonn) 15g, Tian 
Kuizi (Semiaquilegia adoxoides (DC.) makino) 15g, Zihua Diding (Viola ycdoensis Mak.) 20g, Ju Mai (Dianthus superbus L.) 
15g, Ma Chixian (Portulaca oleracea L) 50g, Pu Gongying (Herba taraxaci) 30g. The concoction was prepared by mixing 
the crude drugs in 800ml water, getting 200ml liquor after the drugs were decocted in 800ml water (100 0C for 30 mins 
twice). After cooling, the concoction was stored at 18-24 0C, humidity 55%-70%. The concoction was orally administrated at 
200ml/day divided by milligrams of creatinine per 100 ml for ten days.  
         The therapeutic results were assessed according to the urine cultures. The following standards were used: cure, 
negative culture at 1 week after treatment; persistence, ≥105 colonies of the original organism per ml during treatment; 
relapse, negative culture during therapy and ≥105 colonies of the original organism per ml at follow-up; reinfection, ≥105 
colonies of an organism different from the original organism per ml at follow-up; and superinfection, ≥105 colonies of an 
organism different from the original organism per ml during treatment. This assessment was based on routine bacteriological 
identification of the microorganisms since serotyping was not done. 
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Results 
 
         Among the 33 patients entered into the study, 3 were excluded from final analysis for the following reasons: 
inadequate follow-up for 1 patient, and administration of antibiotics or other protocol violations in 2 patients. 
         The etiologic agents isolated from urine cultures before treatment were (with number of strains in parentheses): 
Escherichia coli (21), Pseudomonas aeruginosa (5), Klebsiella pneumoniae (3), Proteus mirabilis (2), and one each for 
Staphylococcus epidermidis, Staphylococcus aureus, Proteus morganii, and Providencia rettgeri. Two patients were infected 
with two organisms. 
         Most of the patients responded symptomatically to treatment. Bacteriologic outcomes are shown in Table 1. 
50%-100% pathogens (except Proteus morganii) were eradicated by days 5 to 10 of treatment. Chinese herbs eradicated the 
primary pathogen in 68.7% of the patients at the day 10 of treatment. Two patients relapsed (one had abbreviated courses of 
therapy) 6 to 8 days posttreatment. Organisms which recurred included Escherichia coli and Pseudomonas aeruginosa. One 
patient grew Acinetobacter iwoffii on the last day of treatment. Bacterial reinfections occurred 5 to 8 days posttreatment in 
four patients. In all cases of relapse, and reinfection, patients had neurologic bladders, or urinary catheters. 
 
Table 1: Bacteriologic response subclassified by etiology 
% of patients 
Day 5 of treatment Day 10 of treatment 1-week follow-up Organism 
No. of 
patients 
Eradication Persistence Eradication Persistence Eradication Persistence 
Escherichia coli 
Pseudomonas aeruginosa 
Klebsiella pneumoniae 
Proteus mirabilis 
Staphylococcus epidermidis 
Staphylococcus aureus 
Proteus morganii 
20 
5 
2 
2 
1 
1 
1 
45.0 
40.0 
0 
50.0 
0 
0 
0 
55.0 
60.0 
100.0 
50.0 
100.0 
100.0 
100.0 
70.0 
80.0 
50.0 
50.0 
100.0 
100.0 
0 
30.0 
20.0 
50.0 
50.0 
0 
0 
100.0 
65.0 
60.0 
50.0 
50.0 
100.0 
100.0 
0 
35.0 
40.0 
50.0 
50.0 
0 
0 
100.0 
 
 
 
         Adverse reactions observed among the 30 patients were rare. Nausea (6.67%) and mild elevation of hepatic 
enzymes (3.33%) were probably drug related. Nausea disapeared when the therapy ended. Elevated hepatic enzymes resumed 
at the 2-week follow-up. Complaints of nervousness, blurred vision, and aching arms were not associated with objective 
findings and were of equivocal significance.  
         Two patients demonstrated slight increases in serum creatinine on day 10 of treatment. No. 1 patient had a 12.5% 
elevation over baseline and no. 2 had a 13.0% elevation (Table 2). Increased renal impairment was attributed to possible 
nephrotoxic reaction to herbal remedy. The changes in serum creatinine and blood urea nitrogen are depicted in Table 2. One 
patient (no. 2 in Table 2) received small doses of diuretics. Dialysis was not attempted due to the general clinical condition 
and the underlying malignant disease of the patients. Serum creatinine values had improved in these two patients at 4-week 
follow-up.  
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Table 2: Serum creatinine and blood urea nitrogen values in two patients 
Serum creatinine (mg/100ml) Blood urea nitrogen (mg/100ml) 
Patient 
No. 
Creatinine 
Clearance 
Pretreatment 
(ml/min) 
Pretreatment 
Last day of 
treatment 
4-week 
follow-up 
Pretreatment 
Last day 
of  
treatment 
4-week 
follow-up 
1 48 1.6 1.8 1.7 37 40 38 
2 22 2.3 2.6 2.4 34 46 40 
Increase from 
pretreatment 
Values (Mean ± SDα) 
  0.25 ± 0.05 0  
7.50 ± 
4.50 
3.50 ± 2.50 
αSD, Standard deviation 
 
Discussion 
 
         In UTIs, the clearance is abnormal in about half of the cases on the affected side. Contralateral compensation and 
intrarenal compensation mechanisms tend to occur. In addition to these compensation mechanisms, hyperfiltration is present 
in many cases of UTIs with intact or unilaterally damaged kidneys (Francisca et al., 1999). So the management of UTIs in 
patients with renal insufficiency is crucial to prevent renal function deterioration. Some Chinese herbs in the study have been 
reported with antibacterial activity (Tong and Li, 2006). Our early clinical study indicated that oral Chinese herbal concoction 
is effective in UTIs caused by fluoroquinolone-resistant organisms. Another previous research show that anti-adhesion is one 
mode of action for Chinese herbs used against UTIs pathogens (Tong et al., 2011b). These properties have prompted their 
compound prescription uses in the management of UTIs. 
         In the present study of patients with serious UTIs, bacteriuria was eradicated in 68.7% of 30 patients at day 10 of 
treatment. The main factor governing a poor outcome of treatment for these patients seems to be impaired renal function, 
neurogenic bladders, structural abnormalities of the genitourinary tract, or urinary catheters. All two patients who relapsed 6 
to 8 days posttreatment had underlying urologic diseases requiring catheterization. Indwelling urinary catheters further favor 
the colonization of uropathogens by providing a surface for the attachment of host cell binding receptors that are recognized 
by bacterial adhesins. Upon insertion, urinary catheters may damage the protective uroepithelial mucosa, which leads to the 
exposure of new binding sites for bacterial adhesins (Garibaldi et al., 1980). 
         More prolonged treatment in these patients may have been more effective in eradicating their infections. One 
patient who became colonized with Acinetobacter iwoffii on the last day of treatment and the four patients who became 
reinfected with new organisms 5 to 8 days posttreatment, the lack of permanent cure was undoubtedly host related rather than 
drug related. 
         The safety of herbal remedy determines the well being of the patient taking the medication. Oral Chinese herbal 
concoction is well tolerated. Nausea and mild elevation of hepatic enzymes were observed. These adverse reactions 
disappeared after discontinuation of the medication. Although we could not exclude Chinese herbs as a contributory factor, 
these events were probably caused by unrelated underlying problems.  
         The renal function profile is a major concern in drug therapy. Special attention should be directed to patients with 
diminished renal function. Careful monitoring of creatinine clearance are indicated. Our definition of nephrotoxic reaction is 
sensitive. It should be emphasized that interpretation of changes in renal function is difficult in patients with uronephrological 
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disorders. As observed by us, the nephrotoxic reaction to these Chinese herbs is reversible, which is probably due to applying 
the formula for dose adjustment proposed here. Further studies with larger populations are needed to show if the low 
nephrotoxic potential accounted for can be reproduced.  
         In short, the management of UTIs in patients with renal insufficiency requires reduction of dosage to avoid high 
serum concentrations and the concomitant increased risk for concentration-dependent adverse drug events. The appropriate 
duration of Chinese herbal therapy in patients with renal insufficiency is unknown. Duration studies are needed in the future.  
The design of our study has some shortcomings. A randomized-controlled double-blind trial would have been ideal but was 
not deemed feasible in this study given the oral route of administration for Chinese herbal concoction. Obviously this initial 
limited therapeutic trial must be extended to a larger group of patients and include long-term follow-up evaluations before a 
definite conclusion can be drawn.  
         In spite of these limitations, we considered Chinese herbs to be effective and safe in the treatment of UTIs with 
stable impairment of renal function. Increases in dosage intervals or shorter periods of treatment should theoretically result in 
less toxicity, but probably also reduce effectiveness. Prospective studies comparing dosage regimens with regard to these 
factors are required. 
 
 
Acknowledgments 
 
         The help of ZhengPing Qu and Yue Jing, nurses in Department Nephrology, who took care of the patients, was 
greatly appreciated. We acknowledge the help of FangMing Gu for artwork. This study was funded by the Jilin Provincial 
Science & Technology Department. 
 
 
References 
 
1. Bennett WM, Craven R. (1976). Urinary tract infections in patients with severe renal disease. JAMA. 236: 945-948. 
2. .Edwards PR, Ewing, WH. (1955). Identification of Enterobacteriaceae. Burgess Publishing Company, Minneapolis, 
Minn, 25-27. 
3. Francisca A, Hamphrey RH, Marianne T, Amy P. Overall and Single-Kidney Clearance in Children with Urinary Tract 
Infection and Damaged Kidneys. J Nucl Med, 1999, 40: 52-55. 
4. Garibaldi RA, Burke JP, Britt MR, Miller MA, Smith CB. (1980). Meatal colonization and catheter- associated 
bacteriuria. N Engl J Med, 303: 316-318. 
5. Lichtenberger P, Hooton TM. (2008). Complicated urinary tract infections. Curr Infect Dis Rep, 10: 499-504. 
6. WHO. (2002). Traditional Medicine; Growing Needs and Potential, WHO Policy Perspectives on Medicines. World 
Health Organization, Geneva, 1-6. 
7. Yanqing Tong, Hui Li. (2006). In-vitro Antibacterial Activity of the Combination of Herba Violae and Herba Taraxaci in 
Different Proportions. J of Guangzhou University of TCM, 23: 487-492. 
8. YanQing Tong, Qiucheng Wu, DongKai Zhao, Yanru Liu, Mingming Cao, Liping Zhang, Shiming Zeng. (2011a). Effects 
of Chinese herbs on the hemagglutination and adhesion of Escherichia Coli strain in vitro. Afr J Tradit Complement 
Altern Med, 8:82-87. 
9. Yanqing Tong, Yue Jing, Dongkai Zhao, Liping Zhang, Shiming Zeng. (2011b). Fluoroquinolone-resistant 
uncomplicated urinary tract infections, Chinese herbal medicine may provide help. Afr J Tradit Complement Altern Med, 
8(S): 108-114. 
